Alkem Laboratories Sees Sharp Open Interest Surge Amidst Weak Price Action

Open Interest and Volume Dynamics

On 24 Apr 2026, Alkem Laboratories recorded an open interest (OI) of 16,604 contracts, up from 14,294 the previous day, marking an absolute increase of 2,310 contracts or 16.16%. This rise in OI is significant, indicating that new positions are being established rather than existing ones being squared off. The volume for the day stood at 8,755 contracts, which, while lower than the OI, reflects active trading interest in the derivatives market.

The futures segment alone accounted for a value of approximately ₹29,452.85 lakhs, while the options segment’s notional value was substantially higher at ₹3,139.85 crores, culminating in a total derivatives value of ₹29,652.58 lakhs. This disparity highlights the dominance of options trading in Alkem’s derivatives market, often used for hedging or speculative directional bets.

Price Performance and Moving Averages

Despite the surge in derivatives activity, Alkem’s underlying stock price has been under pressure. The stock has declined by 3.60% on the day, underperforming its sector by 1.57% and the broader Sensex by 2.58%. Over the past three consecutive sessions, the stock has lost 5.93%, touching an intraday low of ₹5,355, which is 3% below the previous close. The weighted average price for the day suggests that most volume traded near the lower price levels, indicating selling pressure.

Technically, Alkem is trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a bearish trend. This technical weakness may be prompting traders to take short positions or hedge existing long exposures in the derivatives market, contributing to the open interest rise.

Investor Participation and Liquidity

Investor participation remains robust, with delivery volumes on 23 Apr rising by 6.97% to 80,290 shares compared to the 5-day average. This increase in delivery volume suggests that despite short-term price weakness, some investors are accumulating shares for the long term. The stock’s liquidity is adequate, supporting trade sizes up to ₹1.55 crores based on 2% of the 5-day average traded value, facilitating smooth execution of large trades in both cash and derivatives segments.

Market Positioning and Potential Directional Bets

The sharp increase in open interest amid falling prices and rising volumes suggests that market participants are actively repositioning. The rise in OI typically indicates fresh capital entering the market, which can be interpreted as either new long positions or new shorts. Given the bearish price action and the stock trading below all major moving averages, it is plausible that a significant portion of the new open interest is from short sellers or traders buying put options to hedge downside risk.

However, the elevated delivery volumes hint at some accumulation on the cash side, possibly by long-term investors viewing the current dip as a buying opportunity. This divergence between derivatives and cash market behaviour often reflects a complex interplay of hedging, speculation, and arbitrage strategies.

Alkem’s Mojo Score currently stands at 62.0 with a Mojo Grade of Hold, upgraded from Sell on 10 Apr 2026. This upgrade reflects a cautious optimism based on fundamental and technical factors, but the stock remains vulnerable to near-term volatility given the recent price weakness and mixed market signals.

Sector and Market Context

Within the Pharmaceuticals & Biotechnology sector, Alkem’s 1-day return of -3.60% underperformed the sector’s -1.48% and the Sensex’s -1.02%. This relative underperformance may be contributing to the increased hedging activity in derivatives. The sector itself is facing headwinds from regulatory uncertainties and pricing pressures, which could be weighing on investor sentiment.

Alkem’s market capitalisation stands at ₹63,632.49 crores, categorising it as a mid-cap stock. Mid-cap stocks often exhibit higher volatility compared to large caps, attracting active trading and speculative positioning in derivatives markets.

Implications for Investors

Investors should closely monitor the evolving open interest and volume patterns in Alkem’s derivatives market as they provide valuable clues about market sentiment and potential price direction. The current surge in OI amid price weakness suggests increased bearish positioning or hedging activity, which could prolong the downtrend in the near term.

However, the rising delivery volumes and the recent Mojo Grade upgrade to Hold indicate that some investors are cautiously optimistic about the stock’s medium-term prospects. Those holding Alkem shares may consider protective strategies such as buying put options or tightening stop-loss levels to manage downside risk.

Traders looking for directional opportunities should watch for confirmation signals such as a sustained breakout above key moving averages or a reversal in open interest trends. Until then, the derivatives market activity points to a cautious stance with a bias towards downside risk.

Conclusion

Alkem Laboratories Ltd’s recent spike in open interest by over 16% in its derivatives segment, combined with declining stock prices and rising volumes, reflects a complex market scenario. While the derivatives market suggests increased bearish bets or hedging, the cash market shows signs of selective accumulation. Investors and traders should remain vigilant, balancing the technical weakness with fundamental considerations and sector dynamics before making decisive moves.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →